Medirom Healthcare Technologies Inc
NASDAQ:MRM
Balance Sheet
Balance Sheet Decomposition
Medirom Healthcare Technologies Inc
Medirom Healthcare Technologies Inc
Balance Sheet
Medirom Healthcare Technologies Inc
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
212
|
514
|
1 440
|
371
|
605
|
106
|
0
|
|
| Cash Equivalents |
212
|
514
|
1 440
|
371
|
605
|
106
|
0
|
|
| Total Receivables |
643
|
774
|
560
|
855
|
1 325
|
1 228
|
2 002
|
|
| Accounts Receivables |
626
|
765
|
560
|
855
|
1 325
|
1 228
|
2 002
|
|
| Other Receivables |
17
|
8
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
6
|
6
|
8
|
19
|
114
|
140
|
152
|
|
| Other Current Assets |
73
|
86
|
80
|
138
|
319
|
284
|
223
|
|
| Total Current Assets |
934
|
1 379
|
2 087
|
1 382
|
2 363
|
1 759
|
2 706
|
|
| PP&E Net |
2 273
|
1 999
|
1 815
|
2 249
|
2 380
|
2 541
|
2 509
|
|
| PP&E Gross |
2 273
|
1 999
|
1 815
|
2 249
|
2 380
|
2 541
|
2 509
|
|
| Accumulated Depreciation |
72
|
74
|
84
|
158
|
248
|
296
|
360
|
|
| Intangible Assets |
76
|
78
|
98
|
391
|
404
|
921
|
1 139
|
|
| Goodwill |
64
|
78
|
151
|
600
|
539
|
485
|
389
|
|
| Note Receivable |
110
|
106
|
117
|
102
|
99
|
96
|
84
|
|
| Long-Term Investments |
52
|
14
|
1
|
53
|
53
|
82
|
87
|
|
| Other Long-Term Assets |
1 013
|
1 104
|
1 446
|
975
|
909
|
967
|
1 175
|
|
| Other Assets |
64
|
78
|
151
|
600
|
539
|
485
|
389
|
|
| Total Assets |
4 522
N/A
|
4 758
+5%
|
5 714
+20%
|
5 753
+1%
|
6 747
+17%
|
6 849
+2%
|
8 091
+18%
|
|
| Liabilities | ||||||||
| Accounts Payable |
141
|
123
|
67
|
231
|
208
|
138
|
1 014
|
|
| Accrued Liabilities |
1 147
|
1 152
|
1 547
|
1 621
|
2 153
|
2 025
|
1 118
|
|
| Short-Term Debt |
180
|
180
|
0
|
0
|
0
|
400
|
492
|
|
| Current Portion of Long-Term Debt |
234
|
192
|
242
|
162
|
99
|
100
|
621
|
|
| Other Current Liabilities |
649
|
617
|
796
|
1 182
|
1 182
|
897
|
936
|
|
| Total Current Liabilities |
2 351
|
2 263
|
2 653
|
3 196
|
3 642
|
3 561
|
4 181
|
|
| Long-Term Debt |
343
|
151
|
668
|
747
|
1 150
|
1 051
|
764
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
5
|
255
|
|
| Other Liabilities |
1 946
|
1 744
|
1 901
|
2 018
|
2 015
|
2 022
|
1 957
|
|
| Total Liabilities |
4 640
N/A
|
4 157
-10%
|
5 222
+26%
|
5 961
+14%
|
6 807
+14%
|
6 638
-2%
|
7 157
+8%
|
|
| Equity | ||||||||
| Common Stock |
245
|
595
|
1 179
|
1 223
|
1 223
|
20
|
353
|
|
| Retained Earnings |
723
|
705
|
1 703
|
2 694
|
2 545
|
80
|
229
|
|
| Additional Paid In Capital |
363
|
713
|
1 018
|
1 265
|
1 265
|
114
|
355
|
|
| Treasury Stock |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
118
N/A
|
600
N/A
|
491
-18%
|
208
N/A
|
59
+71%
|
211
N/A
|
933
+343%
|
|
| Total Liabilities & Equity |
4 522
N/A
|
4 758
+5%
|
5 714
+20%
|
5 753
+1%
|
6 747
+17%
|
6 849
+2%
|
8 091
+18%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
5
|
5
|
5
|
5
|
5
|
5
|
8
|
|